Cargando…
A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth
BACKGROUND: Dose-dependent irreversible cardiac toxicity of doxorubicin (DOX) becomes a major obstacle for the clinical use. Nowadays much attention is being paid to combination therapy with DOX and antioxidant agents, which would improve the clinical efficacy by protecting from cardiotoxicity along...
Autores principales: | Zhang, Di, Xu, Qian, Wang, Ning, Yang, Yanting, Liu, Jiaqi, Yu, Guohua, Yang, Xin, Xu, Hui, Wang, Hongbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091483/ https://www.ncbi.nlm.nih.gov/pubmed/30127606 http://dx.doi.org/10.2147/IJN.S170067 |
Ejemplares similares
-
In Vitro and In Vivo Cardioprotective Effects of Curcumin against Doxorubicin-Induced Cardiotoxicity: A Systematic Review
por: Zhang, Qian, et al.
Publicado: (2022) -
Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
por: Cheah, Irwin K., et al.
Publicado: (2023) -
Phoenix dactylifera Protects against Doxorubicin-Induced Cardiotoxicity and Nephrotoxicity
por: Wang, Yuewen, et al.
Publicado: (2019) -
Cardioprotective Roles of β-Hydroxybutyrate Against Doxorubicin Induced Cardiotoxicity
por: Liu, Yihai, et al.
Publicado: (2021) -
Assessment of left heart dysfunction to predict doxorubicin cardiotoxicity in children with lymphoma
por: Chen, Jiaqi, et al.
Publicado: (2023)